This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| ICU | 1877 |
| der | 793 |
| LPS | 777 |
| TNF | 726 |
| II | 470 |
| IL-6 | 447 |
| bei | 352 |
| von | 351 |
| ± | 347 |
| C | 338 |
| mg | 327 |
| Care | 316 |
| mit | 308 |
| T | 298 |
| und | 285 |
| APACHE | 284 |
| ARDS | 276 |
| AKI | 262 |
| kg | 248 |
| SIRS | 248 |
| OBJECTIVES | 247 |
| METHODS | 235 |
| eine | 230 |
| IL-10 | 216 |
| Sepsis | 216 |
| einer | 206 |
| Fig | 201 |
| IL | 199 |
| Patienten | 194 |
| CI | 191 |
| Hospital | 188 |
| werden | 186 |
| Schock | 185 |
| B | 183 |
| IL-1 | 177 |
| zu | 177 |
| INTRODUCTION | 171 |
| PCT | 168 |
| L | 165 |
| CRP | 164 |
| des | 159 |
| Intensive | 158 |
| RNA | 153 |
| den | 151 |
| Group | 150 |
| IL-8 | 150 |
| durch | 150 |
| CSF | 147 |
| A | 144 |
| auf | 142 |
| VAP | 142 |
| zur | 141 |
| kann | 140 |
| nicht | 139 |
| IgM | 138 |
| ECMO | 138 |
| Critical | 137 |
| University | 136 |
| PMN | 136 |
| S | 133 |
| MOF | 130 |
| ist | 126 |
| E. | 126 |
| das | 124 |
| CLP | 121 |
| G | 118 |
| oder | 117 |
| I | 112 |
| III | 111 |
| M | 109 |
| sich | 105 |
| MODS | 105 |
| IFN | 105 |
| CONCLUSION | 105 |
| als | 104 |
| auch | 102 |
| CD14 | 102 |
| ein | 101 |
| min | 99 |
| wird | 98 |
| monocyte | 97 |
| sind | 95 |
| IVIG | 95 |
| SD | 93 |
| CT | 93 |
| ammatory | 92 |
| S. | 91 |
| Unit | 89 |
| LOS | 89 |
| Medical | 88 |
| ALI | 88 |
| • | 88 |
| Medicine | 87 |
| Table | 87 |
| TLR4 | 86 |
| MAP | 85 |
| α | 85 |
| nach | 83 |
| January | 83 |
| ml | 82 |
| einem | 82 |
| ELISA | 81 |
| SAPS | 81 |
| USA | 81 |
| DR | 79 |
| CO | 79 |
| IQR | 79 |
| E | 78 |
| D | 78 |
| ng | 77 |
| CD4 | 77 |
| IV | 76 |
| Bei | 76 |
| IL-4 | 75 |
| ROC | 75 |
| MV | 74 |
| Department | 74 |
| DIC | 74 |
| Ò | 72 |
| CRRT | 71 |
| C. | 71 |
| pg | 69 |
| UK | 69 |
| CPB | 69 |
| AUC | 68 |
| Germany | 68 |
| ~ | 67 |
| infl | 67 |
| PAF | 67 |
| IgG | 67 |
| GM | 67 |
| u. | 66 |
| TBI | 66 |
| B. | 65 |
| CA | 65 |
| F | 65 |
| IL-12 | 65 |
| IL-2 | 65 |
| pH | 65 |
| R | 65 |
| Score | 64 |
| Der | 63 |
| December | 63 |
| ICUs | 61 |
| ICP | 60 |
| HIV | 60 |
| Toll | 59 |
| ET | 59 |
| V | 59 |
| sepsis-3 | 59 |
| NIV | 58 |
| N | 58 |
| HLA | 58 |
| mRNA | 57 |
| alfa | 57 |
| U | 57 |
| PCR | 57 |
| ARF | 57 |
| J. | 56 |
| können | 55 |
| Study | 55 |
| HES | 55 |
| z. | 54 |
| vivo | 54 |
| Pseudomonas | 54 |
| J | 54 |
| HS | 54 |
| Abb | 53 |
| Mann | 53 |
| dem | 53 |
| selectin | 53 |
| GCS | 52 |
| es | 51 |
| Whitney | 51 |
| United | 51 |
| Tabelle | 51 |
| Health | 51 |
| CMV | 51 |
| A. | 51 |
| ANOVA | 50 |
| ED | 50 |
| Abschn | 50 |
| TLR2 | 50 |
| K | 50 |
| fl | 50 |
| lg | 49 |
| Therapie | 49 |
| NOS | 48 |
| CVP | 48 |
| nur | 47 |
| TGF | 47 |
| NE | 47 |
| Acute | 46 |
| HR | 46 |
| RRT | 46 |
| dl | 46 |
| dass | 45 |
| PPV | 45 |
| National | 45 |
| NK | 45 |
| MO | 45 |
| ISS | 45 |
| M. | 44 |
| AT | 44 |
| CPR | 44 |
| ECLS | 44 |
| Society | 44 |
| MIF | 44 |
| PIRO | 44 |
| septischen | 44 |
| p<0.01 | 44 |
| zienz | 43 |
| LV | 43 |
| ATP | 42 |
| Assessment | 42 |
| Escherichia | 42 |
| Research | 42 |
| sepsis-2 | 42 |
| wie | 42 |
| damit | 41 |
| International | 41 |
| Emergency | 41 |
| Gabe | 40 |
| BMI | 40 |
| EC | 40 |
| H | 40 |
| SS | 40 |
| States | 40 |
| einen | 40 |
| zum | 40 |
| US | 39 |
| i.v | 39 |
| fi | 39 |
| eines | 39 |
| aus | 39 |
| Glasgow | 39 |
| Einsatz | 39 |
| Center | 39 |
| CD | 39 |
| Japan | 38 |
| April | 38 |
| PCI | 38 |
| P. | 38 |
| November | 38 |
| SP | 38 |
| über | 38 |
| für | 38 |
| jedoch | 38 |
| TLR | 38 |
| Surgery | 37 |
| DETecT | 37 |
| SOFA | 37 |
| COVID-19 | 37 |
| TLR3 | 37 |
| noch | 37 |
| sha | 37 |
| mmol | 36 |
| NO | 36 |
| MD | 36 |
| HMGB1 | 36 |
| G. | 36 |
| Das | 36 |
| CVVH | 36 |
| Association | 36 |
| AP | 36 |
| Candida | 35 |
| Clinical | 35 |
| Letalität | 35 |
| Ca | 35 |
| Institute | 35 |
| France | 35 |
| Neutrophil | 35 |
| October | 35 |
| Organ | 35 |
| Surviving | 35 |
| WBC | 35 |
| IP-10 | 34 |
| BAL | 34 |
| BT | 34 |
| July | 34 |
| Protein | 34 |
| R. | 34 |
| drotrecogin | 34 |
| häufi | 34 |
| P | 33 |
| < | 33 |
| Eine | 33 |
| Hg | 33 |
| LEH | 33 |
| Chi | 33 |
| Patient | 33 |
| ST | 33 |
| SVV | 33 |
| sein | 33 |
| Werdan | 33 |
| ROS | 33 |
| OHCA | 32 |
| BPI | 32 |
| CD8 | 32 |
| D. | 32 |
| Fc | 32 |
| General | 32 |
| L. | 32 |
| March | 32 |
| RBC | 32 |
| RV | 32 |
| SARS | 32 |
| TM | 32 |
| TRAIL | 32 |
| Trauma | 32 |
| kommt | 32 |
| ug | 32 |
| PS | 31 |
| CVC | 31 |
| HCV | 31 |
| IU | 31 |
| NIRS | 31 |
| SE | 31 |
| Staphylococcus | 31 |
| Student | 31 |
| bis | 31 |
| SOD | 31 |
| ECG | 30 |
| MT | 30 |
| American | 30 |
| CD18 | 30 |
| Campaign | 30 |
| Evaluation | 30 |
| IAP | 30 |
| Index | 30 |
| K. | 30 |
| LBP | 30 |
| GH | 30 |
| NS | 30 |
| SC | 30 |
| Septic | 30 |
| signifi | 30 |
| TEG | 30 |
| TNFa | 30 |
| defi | 30 |
| kgKG | 30 |
| mm | 30 |
| PGE | 30 |
| T4 | 29 |
| CPAP | 29 |
| Herz | 29 |
| SPSS | 29 |
| Shock | 29 |
| kritisch | 29 |
| TBSA | 29 |
| Wirkung | 29 |
| interleukin-6 | 29 |
| mL | 29 |
| Human | 28 |
| IgA | 28 |
| IL-18 | 28 |
| Management | 28 |
| Fisher | 28 |
| Committee | 28 |
| CABG | 28 |
| KC | 28 |
| EGDT | 28 |
| OBJECTIVE | 28 |
| StO | 28 |
| T0 | 28 |
| kardiogenen | 28 |
| lra | 28 |
| κB | 28 |
| ohne | 28 |
| zymosan | 28 |
| Schocks | 28 |
| IgE | 27 |
| CAM | 27 |
| China | 27 |
| DNA | 27 |
| EPO | 27 |
| Hemodynamic | 27 |
| IVC | 27 |
| PEEP | 27 |
| Procalcitonin | 27 |
| Registry | 27 |
| SB | 27 |
| Wilcoxon | 27 |
| _ | 27 |
| i.p | 27 |
| mmHg | 27 |
| System | 26 |
| Annexin | 26 |
| COPD | 26 |
| GSH | 26 |
| IMV | 26 |
| I~ | 26 |
| Lösungen | 26 |
| NF | 26 |
| PAI-1 | 26 |
| LXA4 | 26 |
| T2 | 26 |
| TPN | 26 |
| sowie | 26 |
| VS | 26 |
| Wistar | 26 |
| aber | 26 |
| beim | 26 |
| führen | 26 |
| TF | 26 |
| EF | 25 |
| Failure | 25 |
| Europe | 25 |
| AA | 25 |
| DC | 25 |
| College | 25 |
| Circular | 25 |
| ITU | 25 |
| Hb | 25 |
| HUVEC | 25 |
| June | 25 |
| New | 25 |
| PMA | 25 |
| PSV | 25 |
| Physiology | 25 |
| dieser | 25 |
| führt | 25 |
| γ | 25 |
| MPO | 25 |
| Doppler | 24 |
| Kupffer | 24 |
| IL-1β | 24 |
| IL-13 | 24 |
| Gram | 24 |
| Ein | 24 |
| C3 | 24 |
| Consensus | 24 |
| CFU | 24 |
| CCI | 24 |
| ACTH | 24 |
| MHC | 24 |
| MA | 24 |
| BMMC | 24 |
| MI | 24 |
| TLR9 | 24 |
| PP | 24 |
| sollte | 24 |
| max | 24 |
| diese | 24 |
| die | 24 |
| rBPI23 | 24 |
| TLR7 | 24 |
| Scale | 24 |
| SNP | 24 |
| Ringer | 24 |
| Reaktionen | 24 |
| ScvO | 24 |
| ESICM | 23 |
| NAVA | 23 |
| MRSA | 23 |
| Immunology | 23 |
| HLI | 23 |
| FFP | 23 |
| CAP | 23 |
| E2 | 23 |
| CpG | 23 |
| BP | 23 |
| BK | 23 |
| Na | 23 |
| NMMA | 23 |
| RR | 23 |
| PBMC | 23 |
| group | 23 |
| β | 23 |
| ® | 23 |
| Prognose | 23 |
| p<0.05 | 23 |
| inotropic | 23 |
| septischem | 23 |
| TI | 23 |
| Spain | 23 |
| Sham | 23 |
| Sepsis-3 | 23 |
| CD16 | 22 |
| CNS | 22 |
| CoV-2 | 22 |
| EWS | 22 |
| HC | 22 |
| IC | 22 |
| NAME | 22 |
| NAC | 22 |
| May | 22 |
| PTX | 22 |
| Royal | 22 |
| September | 22 |
| Syndrome | 22 |
| bronchoalveolar | 22 |
| i | 22 |
| sehr | 22 |
| Pearson | 22 |
| IL6 | 21 |
| PD | 21 |
| P2 | 21 |
| NT | 21 |
| M1 | 21 |
| Cox | 21 |
| ICAM-1 | 21 |
| H. | 21 |
| DOI | 21 |
| PGE2 | 21 |
| Behandlung | 21 |
| Altman | 21 |
| PFO | 21 |
| Med | 21 |
| Plasma | 21 |
| kardiogenem | 21 |
| SAH | 21 |
| sie | 21 |
| rhG | 21 |
| meta | 21 |
| keine | 21 |
| proinfl | 21 |
| dabei | 21 |
| Zytokine | 21 |
| ZO-1 | 21 |
| TLRs | 21 |
| Sie | 21 |
| Diese | 20 |
| HMGB-1 | 20 |
| Greece | 20 |
| GI | 20 |
| FiO | 20 |
| European | 20 |
| Endotoxin | 20 |
| ER | 20 |
| APC | 20 |
| IR | 20 |
| B4 | 20 |
| August | 20 |
| Anstieg | 20 |
| Acinetobacter | 20 |
| ADP | 20 |
| A1 | 20 |
| IL-1ra | 20 |
| Conference | 20 |
| Kreislauf | 20 |
| Y | 20 |
| PA | 20 |
| muss | 20 |
| multicentre | 20 |
| mehr | 20 |
| infolge | 20 |
| cm | 20 |
| akuten | 20 |
| n=6 | 20 |
| Xa | 20 |
| T. | 20 |
| RCT | 20 |
| PT | 20 |
| PLA | 20 |
| PDT | 20 |
| VAS | 20 |
| Ig | 19 |
| NSE | 19 |
| MP | 19 |
| Lipopolysaccharide | 19 |
| LTB4 | 19 |
| L1 | 19 |
| Kranken | 19 |
| Cell | 19 |
| IABP | 19 |
| Heart | 19 |
| Bland | 19 |
| BNP | 19 |
| AG | 19 |
| PaO | 19 |
| PBS | 19 |
| PHA | 19 |
| etwa | 19 |
| TCD | 19 |
| PiCCO | 19 |
| pat | 19 |
| n= | 19 |
| innerhalb | 19 |
| bzw | 19 |
| bacteraemic | 19 |
| Vergleich | 19 |
| Studie | 19 |
| Stickoxid | 19 |
| SSC | 19 |
| SEM | 19 |
| Review | 19 |
| Regel | 19 |
| ODN | 18 |
| M2 | 18 |
| Mediatoren | 18 |
| NC | 18 |
| Sepsispatienten | 18 |
| PMNs | 18 |
| RT | 18 |
| GRANT | 18 |
| Guidelines | 18 |
| ACh | 18 |
| Control | 18 |
| Chronic | 18 |
| CH | 18 |
| CC | 18 |
| Ang | 18 |
| Adrenalin | 18 |
| AIDS | 18 |
| SBT | 18 |
| neben | 18 |
| Substanzen | 18 |
| hydrocortisone | 18 |
| Sweden | 18 |
| unter | 18 |
| st | 18 |
| p>0.05 | 18 |
| multiorgan | 18 |
| lymphopenia | 18 |
| veno | 18 |
| kommen | 18 |
| dann | 18 |
| anti | 18 |
| WT | 18 |
| Volumensubstitution | 18 |
| VO | 18 |
| Th17 | 18 |
| T3 | 18 |
| Herzindex | 17 |
| I. | 17 |
| Interleukin | 17 |
| MDR | 17 |
| Interleukin-6 | 17 |
| KO | 17 |
| London | 17 |
| GBS | 17 |
| HP | 17 |
| ACCP | 17 |
| Figure | 17 |
| February | 17 |
| Dawley | 17 |
| Blutdruck | 17 |
| Bedeutung | 17 |
| BN | 17 |
| BMT | 17 |
| A2 | 17 |
| NFκB | 17 |
| MPS | 17 |
| Tregs | 17 |
| Nach | 17 |
| lässt | 17 |
| Schockformen | 17 |
| wenn | 17 |
| sondern | 17 |
| sera | 17 |
| scheint | 17 |
| p= | 17 |
| nan | 17 |
| miRNAs | 17 |
| pts | 17 |
| h. | 17 |
| ed | 17 |
| circRNAs | 17 |
| administration | 17 |
| TB | 17 |
| T1 | 17 |
| SvO | 17 |
| flagellin | 17 |
| Dept | 16 |
| Cardiac | 16 |
| Coma | 16 |
| Defi | 16 |
| INR | 16 |
| EAA | 16 |
| EMS | 16 |
| EN | 16 |
| CD3 | 16 |
| CEA | 16 |
| AE | 16 |
| BSA | 16 |
| BS | 16 |
| Athens | 16 |
| Aktivierung | 16 |
| Administration | 16 |
| Abnahme | 16 |
| ASC | 16 |
| ASA | 16 |
| Italy | 16 |
| ACS | 16 |
| -1 | 16 |
| Ill | 16 |
| ITBV | 16 |
| MDA | 16 |
| Treg | 16 |
| NEC | 16 |
| sogar | 16 |
| n=10 | 16 |
| klinischen | 16 |
| kallikrein | 16 |
| el | 16 |
| ca | 16 |
| Vt | 16 |
| Vasopressin | 16 |
| Ursache | 16 |
| Z. | 16 |
| TNFα | 16 |
| Reaktion | 16 |
| TGP | 16 |
| Non | 16 |
| PMV | 16 |
| PO | 16 |
| NIMV | 16 |
| SICU | 16 |
| Sequential | 16 |
| Sprague | 16 |
| Supplementary | 16 |
| Ea | 15 |
| LVEF | 15 |
| Immunoglobulin | 15 |
| IL-7 | 15 |
| IL-1Ra | 15 |
| Herzinfarkt | 15 |
| HCAP | 15 |
| Global | 15 |
| Gln | 15 |
| FMLP | 15 |
| Ethics | 15 |
| MCS | 15 |
| Dysfunktion | 15 |
| Diseases | 15 |
| DFO | 15 |
| CrCl | 15 |
| CS | 15 |
| CNTF | 15 |
| Berlin | 15 |
| BTT | 15 |
| Auch | 15 |
| Anesthesiology | 15 |
| -5 | 15 |
| LoS | 15 |
| EOL | 15 |
| Meier | 15 |
| thrombomodulin | 15 |
| Monocyte | 15 |
| p=0.01 | 15 |
| p<0.0001 | 15 |
| neopterin | 15 |
| isoflurane | 15 |
| control | 15 |
| classifi | 15 |
| bereits | 15 |
| ammation | 15 |
| allerdings | 15 |
| \ | 15 |
| erhöht | 15 |
| Willebrand | 15 |
| SCCM | 15 |
| VOT | 15 |
| PE | 15 |
| POCA | 15 |
| Reanimation | 15 |
| Pentaglobin | 15 |
| TLR5 | 15 |
| TNFR | 15 |
| TTE | 15 |
| V. | 15 |
| FACS | 14 |
| IHCA | 14 |
| Foundation | 14 |
| HPLC | 14 |
| HSCT | 14 |
| Hypovolämie | 14 |
| IAH | 14 |
| KL | 14 |
| IL-17 | 14 |
| Inc. | 14 |
| India | 14 |
| Intensivpatienten | 14 |
| Katecholamine | 14 |
| Epidemiology | 14 |
| F. | 14 |
| AMI | 14 |
| EVLW | 14 |
| Dobutamin | 14 |
| Disease | 14 |
| DEX | 14 |
| D1 | 14 |
| Charlson | 14 |
| CDI | 14 |
| CD1 | 14 |
| C3a | 14 |
| Blutung | 14 |
| Anaphylaxie | 14 |
| Analysis | 14 |
| MFI | 14 |
| ADL | 14 |
| -3 | 14 |
| Klebsiella | 14 |
| Kg | 14 |
| MIP | 14 |
| erforderlich | 14 |
| Tage | 14 |
| Trial | 14 |
| UWS | 14 |
| VE | 14 |
| acid | 14 |
| c~ | 14 |
| glycocalyx | 14 |
| Stress | 14 |
| haben | 14 |
| iv | 14 |
| konnte | 14 |
| Munich | 14 |
| novo | 14 |
| post | 14 |
| TT | 14 |
| ndet | 14 |
| SmartCare | 14 |
| PROWESS | 14 |
| SeptiCyte | 14 |
| NLR | 14 |
| PAC | 14 |
| PBW | 14 |
| PH | 14 |
| PMNL | 14 |
| Myokarddepression | 14 |
| Pt | 14 |
| RCA | 14 |
| ROSC | 14 |
| S1 | 14 |
| RASS | 14 |
| School | 14 |
| Kingdom | 13 |
| Granulocyte | 13 |
| Herzinsuffi | 13 |
| IP | 13 |
| Ireland | 13 |
| Kaplan | 13 |
| MET | 13 |
| MCA | 13 |
| MOSF | 13 |
| Müller | 13 |
| NMA | 13 |
| NTM | 13 |
| GRV | 13 |
| Gramnegative | 13 |
| CR3 | 13 |
| GP | 13 |
| Falle | 13 |
| Factor | 13 |
| ETP | 13 |
| EFL | 13 |
| Druck | 13 |
| City | 13 |
| BW | 13 |
| BE | 13 |
| Auftreten | 13 |
| AUROC | 13 |
| APRV | 13 |
| -6 | 13 |
| P1 | 13 |
| Netherlands | 13 |
| levosimendan | 13 |
| POF | 13 |
| Wahl | 13 |
| PRBC | 13 |
| weniger | 13 |
| tPA | 13 |
| sowohl | 13 |
| miRNA | 13 |
| metformin | 13 |
| klinische | 13 |
| interleukin-8 | 13 |
| imipenem | 13 |
| gibt | 13 |
| dafür | 13 |
| aller | 13 |
| alle | 13 |
| aufgrund | 13 |
| Verlauf | 13 |
| TAVI | 13 |
| Phase | 13 |
| SIS | 13 |
| SSS | 13 |
| Stadium | 13 |
| VLBW | 13 |
| Störungen | 13 |
| Streptococcus | 13 |
| TIR | 13 |
| TNF-~ | 13 |
| Therapy | 13 |
| UFH | 13 |
| VA | 13 |
| Effekte | 12 |
| IL-3 | 12 |
| FITC | 12 |
| Fieber | 12 |
| Folge | 12 |
| GC | 12 |
| HBV | 12 |
| HO-1 | 12 |
| ID | 12 |
| Methods | 12 |
| Intensivstation | 12 |
| Intravenous | 12 |
| KDIGO | 12 |
| Leukocyte | 12 |
| Listeria | 12 |
| Ludwig | 12 |
| Lungenödem | 12 |
| MARS | 12 |
| EDRF | 12 |
| EEG | 12 |
| Akut | 12 |
| ECCO | 12 |
| EA | 12 |
| PAMV | 12 |
| 1C | 12 |
| AOF | 12 |
| AST | 12 |
| ATX | 12 |
| America | 12 |
| Antithrombin | 12 |
| BGC | 12 |
| BSI | 12 |
| Bildung | 12 |
| CD64 | 12 |
| CMI | 12 |
| Centre | 12 |
| DHEA | 12 |
| DO | 12 |
| DXS | 12 |
| Definitions | 12 |
| Monitoring | 12 |
| HDU | 12 |
| PCC | 12 |
| mittels | 12 |
| Zur | 12 |
| anderen | 12 |
| baumannii | 12 |
| besteht | 12 |
| eher | 12 |
| erhöhte | 12 |
| ersten | 12 |
| ggf | 12 |
| ned | 12 |
| Veränderungen | 12 |
| p=0.002 | 12 |
| phx | 12 |
| profi | 12 |
| range | 12 |
| vor | 12 |
| weiterhin | 12 |
| ~g | 12 |
| PICS | 12 |
| Zn | 12 |
| haloperidol | 12 |
| Vasodilatation | 12 |
| Selectin | 12 |
| Panel | 12 |
| Use | 12 |
| Prevention | 12 |
| Resuscitation | 12 |
| S3 | 12 |
| SAP | 12 |
| SIR | 12 |
| Saline | 12 |
| Schockpatienten | 12 |
| SBP | 12 |
| TNFc~ | 12 |
| Test | 12 |
| SpO | 12 |
| Übersicht | 12 |
| Steigerung | 12 |
| Swedish | 12 |
| Systems | 12 |
| Serum | 12 |
| Fas | 11 |
| F4H5 | 11 |
| Extracellular | 11 |
| Expression | 11 |
| Diagnostik | 11 |
| ETA | 11 |
| EPCR | 11 |
| Dopamin | 11 |
| G2 | 11 |
| Freiburg | 11 |
| JAAM | 11 |
| GFAP | 11 |
| Gefäßwiderstand | 11 |
| H1N1 | 11 |
| HH | 11 |
| HSV | 11 |
| ICAM | 11 |
| Immune | 11 |
| Immunosuppression | 11 |
| Intensivmedizin | 11 |
| Kruskal | 11 |
| Dental | 11 |
| Development | 11 |
| Als | 11 |
| Daten | 11 |
| Birmingham | 11 |
| 24h | 11 |
| ACKNOWLEDGMENT | 11 |
| ACR | 11 |
| Lactate | 11 |
| Anaesthesia | 11 |
| Anti | 11 |
| BBV | 11 |
| BC | 11 |
| Beatmung | 11 |
| Belgium | 11 |
| Blood | 11 |
| Congress | 11 |
| Bonferroni | 11 |
| Boston | 11 |
| CBT | 11 |
| CCT | 11 |
| CD11b | 11 |
| CG | 11 |
| CIN | 11 |
| Cardiogenic | 11 |
| Cl | 11 |
| Cochrane | 11 |
| LD | 11 |
| Effect | 11 |
| MS | 11 |
| n=12 | 11 |
| da | 11 |
| dar | 11 |
| diesen | 11 |
| gg | 11 |
| i. | 11 |
| insbesondere | 11 |
| klinisch | 11 |
| lm | 11 |
| mcg | 11 |
| möglich | 11 |
| n=5 | 11 |
| akutem | 11 |
| nd | 11 |
| nmol | 11 |
| nonsurvivors | 11 |
| schweren | 11 |
| systemischen | 11 |
| vom | 11 |
| weiteren | 11 |
| zwar | 11 |
| » | 11 |
| NGAL | 11 |
| antigen | 11 |
| selten | 11 |
| West | 11 |
| Schweregrad | 11 |
| NICU | 11 |
| Wallis | 11 |
| NIH | 11 |
| Network | 11 |
| PMX | 11 |
| POC | 11 |
| Produktion | 11 |
| RIFLE | 11 |
| RPMI | 11 |
| SAC | 11 |
| PICU | 11 |
| Senkung | 11 |
| Thrombin | 11 |
| Spearman | 11 |
| VRI | 11 |
| VD | 11 |
| Treatment | 11 |
| UCH | 11 |
| Th | 11 |
| TXA | 11 |
| Sterblichkeit | 11 |
| VR | 11 |
| HDL | 10 |
| HD | 10 |
| GAPDH | 10 |
| HA | 10 |
| Gly | 10 |
| Gerinnung | 10 |
| Gene | 10 |
| GTN | 10 |
| FC | 10 |
| Für | 10 |
| Free | 10 |
| Faist | 10 |
| LT | 10 |
| Es | 10 |
| Empfehlungen | 10 |
| Efficacy | 10 |
| Hemmung | 10 |
| EU | 10 |
| HF | 10 |
| Infectious | 10 |
| High | 10 |
| Infektion | 10 |
| EOLC | 10 |
| LAL | 10 |
| LA | 10 |
| Kidney | 10 |
| Jahren | 10 |
| Intervention | 10 |
| Injury | 10 |
| Inc | 10 |
| IAI | 10 |
| Impact | 10 |
| IgGAM | 10 |
| IRF | 10 |
| IR+F | 10 |
| ILl | 10 |
| ICUCA | 10 |
| IB | 10 |
| ET-1 | 10 |
| BKCA | 10 |
| Durch | 10 |
| Drotrecogin | 10 |
| BSBL | 10 |
| BM | 10 |
| BCG | 10 |
| BBB | 10 |
| BA | 10 |
| Appendix | 10 |
| Ang-1 | 10 |
| Anaesthesiology | 10 |
| Age | 10 |
| Acc | 10 |
| Abfall | 10 |
| Ab | 10 |
| ANC | 10 |
| AM | 10 |
| AGI | 10 |
| ADMA | 10 |
| ADM | 10 |
| BWC | 10 |
| Bild | 10 |
| Board | 10 |
| Crit | 10 |
| Dr. | 10 |
| Die | 10 |
| Dellinger | 10 |
| De | 10 |
| Da | 10 |
| DTH | 10 |
| DAA | 10 |
| Confusion | 10 |
| C4 | 10 |
| Chest | 10 |
| Chaudry | 10 |
| Cancer | 10 |
| CRT | 10 |
| CP-0127 | 10 |
| CHO | 10 |
| CBF | 10 |
| LDH | 10 |
| Safety | 10 |
| Levosimendan | 10 |
| Syndrom | 10 |
| bacteraemia | 10 |
| anesthesia | 10 |
| Zymosan | 10 |
| Zunahme | 10 |
| Zellen | 10 |
| Wang | 10 |
| W | 10 |
| Vor | 10 |
| Verfahren | 10 |
| Verbesserung | 10 |
| Units | 10 |
| Uniplas | 10 |
| Trust | 10 |
| Toxine | 10 |
| TTV | 10 |
| TLR8 | 10 |
| TLR1 | 10 |
| chi | 10 |
| circRNA | 10 |
| committee | 10 |
| refi | 10 |
| Lung | 10 |
| ΔCI | 10 |
| zwischen | 10 |
| zeigen | 10 |
| trotz | 10 |
| sollten | 10 |
| simplex | 10 |
| prostacyclin | 10 |
| defensin | 10 |
| möglichst | 10 |
| microRNA | 10 |
| lmol | 10 |
| hämodynamischen | 10 |
| hypovolämischen | 10 |
| hervorrufen | 10 |
| defensins | 10 |
| TFPI | 10 |
| cGMP | 10 |
| Stunden | 10 |
| PLR | 10 |
| PKC | 10 |
| PGI | 10 |
| OSF | 10 |
| OOH | 10 |
| O. | 10 |
| O | 10 |
| Noradrenalin | 10 |
| NSS | 10 |
| NG | 10 |
| N. | 10 |
| Müller- | 10 |
| Myokardinfarkt | 10 |
| MRC | 10 |
| MR | 10 |
| MBL | 10 |
| Studies | 10 |
| MAPK | 10 |
| PLA2 | 10 |
| Notaufnahme | 10 |
| POCD | 10 |
| SBI | 10 |
| Studien | 10 |
| Scotland | 10 |
| Schädigung | 10 |
| Salmonella | 10 |
| SVR | 10 |
| STMV | 10 |
| SHOCK | 10 |
| SDMA | 10 |
| Stabilisierung | 10 |
| SBF | 10 |
| SA | 10 |
| S100A8 | 10 |
| Renal | 10 |
| Rahmen | 10 |
| PRRs | 10 |
| PRR | 10 |
| HCl | 9 |
| ICG | 9 |
| I.P. | 9 |
| Hypotonie | 9 |
| Hochman | 9 |
| Hirudin | 9 |
| Herzzeitvolumen | 9 |
| Herzen | 9 |
| HEM | 9 |
| Freisetzung | 9 |
| HA-1A | 9 |
| GA | 9 |
| Inhibitor | 9 |
| Faktoren | 9 |
| FDR | 9 |
| Ergebnisse | 9 |
| Endothelin | 9 |
| Elebute | 9 |
| Empfehlung | 9 |
| IJVT | 9 |
| NOD2 | 9 |
| Institut | 9 |
| Inzidenz | 9 |
| EIT | 9 |
| NPPV | 9 |
| NI | 9 |
| NGF | 9 |
| nan | 9 |
| Model | 9 |
| Method | 9 |
| MaR1 | 9 |
| MDRD | 9 |
| MCP-1 | 9 |
| Log | 9 |
| Laboratory | 9 |
| LR | 9 |
| LOMT | 9 |
| LMWH | 9 |
| LIF | 9 |
| Ischämie | 9 |
| EPA | 9 |
| A4 | 9 |
| E-75 | 9 |
| Adult | 9 |
| Bacteremia | 9 |
| BU | 9 |
| BI | 9 |
| Australia | 9 |
| Ausmaß | 9 |
| Asp | 9 |
| Apache | 9 |
| Anwendung | 9 |
| AWS | 9 |
| Dysregulation | 9 |
| AP-1 | 9 |
| ALF | 9 |
| AIS | 9 |
| ACKNOWLEDGEMENT | 9 |
| ACE2 | 9 |
| Nachlast | 9 |
| A3 | 9 |
| 1B | 9 |
| Blutfl | 9 |
| Bone | 9 |
| C1 | 9 |
| C57BL/6 | 9 |
| Dosierung | 9 |
| Distress | 9 |
| Delirium | 9 |
| Data | 9 |
| DVT | 9 |
| DT | 9 |
| DISCUSSION | 9 |
| DHA | 9 |
| DCI | 9 |
| Cytokines | 9 |
| Circ | 9 |
| CV | 9 |
| CPC | 9 |
| CHI | 9 |
| CFS | 9 |
| CD71 | 9 |
| CD40 | 9 |
| NPV | 9 |
| Maßnahmen | 9 |
| Novel | 9 |
| gsten | 9 |
| mDCs | 9 |
| leucocyte | 9 |
| landiolol | 9 |
| kardiopulmonalen | 9 |
| interleukin-1 | 9 |
| intensivists | 9 |
| inflammasome | 9 |
| heparin | 9 |
| gezeigt | 9 |
| Zeit | 9 |
| general | 9 |
| ebenso | 9 |
| dagegen | 9 |
| cryoprecipitate | 9 |
| benefi | 9 |
| b.w | 9 |
| ammasome | 9 |
| abstract | 9 |
| minocycline | 9 |
| ms | 9 |
| n.s | 9 |
| nden | 9 |
| Nursing | 9 |
| μmol | 9 |
| ~n | 9 |
| worden | 9 |
| wobei | 9 |
| uss | 9 |
| stellt | 9 |
| square | 9 |
| spezifi | 9 |
| specifi | 9 |
| scheinen | 9 |
| s. | 9 |
| rec | 9 |
| rd | 9 |
| positiv | 9 |
| poly(I | 9 |
| plasmacytoid | 9 |
| ab | 9 |
| n=13 | 9 |
| Wirksamkeit | 9 |
| Pro | 9 |
| Roche | 9 |
| Rio | 9 |
| Rezeptoren | 9 |
| Regional | 9 |
| Reduktion | 9 |
| Ras | 9 |
| RF | 9 |
| RBCT | 9 |
| PTSD | 9 |
| SCS | 9 |
| PLF | 9 |
| PK | 9 |
| PI | 9 |
| PGI2 | 9 |
| Organversagen | 9 |
| OR | 9 |
| WD | 9 |
| OPN-305 | 9 |
| Rolle | 9 |
| RAW264.7 | 9 |
| SMA | 9 |
| Third | 9 |
| VT | 9 |
| VFD | 9 |
| VCAM-1 | 9 |
| Ursachen | 9 |
| UTI | 9 |
| Trials | 9 |
| Time | 9 |
| Thomas | 9 |
| UO | 9 |
| TX | 9 |
| TRIF | 9 |
| TNM | 9 |
| Survival | 9 |
| Surgical | 9 |
| Th2 | 9 |
| Sciences | 9 |
| St. | 9 |
| NHS | 8 |
| Messung | 8 |
| Makrophagen | 8 |
| Marburg | 8 |
| Mechanismen | 8 |
| Mortality | 8 |
| Mitralinsuffi | 8 |
| Molecular | 8 |
| Möglichkeit | 8 |
| MLA | 8 |
| MRI | 8 |
| Katecholaminen | 8 |
| MBI | 8 |
| Louis | 8 |
| Life | 8 |
| Leber | 8 |
| Kreislaufschock | 8 |
| Kranker | 8 |
| IVIg | 8 |
| Infl | 8 |
| Induktion | 8 |
| NOD1 | 8 |
| NJT | 8 |
| Pes | 8 |
| NPT | 8 |
| NaCl | 8 |
| IRB | 8 |
| Preoperative | 8 |
| Post | 8 |
| Pharmaceuticals | 8 |
| Peak | 8 |
| Patients | 8 |
| PV | 8 |
| PTS | 8 |
| POSSUM | 8 |
| PLTP | 8 |
| PEC | 8 |
| PDGF | 8 |
| PCA | 8 |
| PC | 8 |
| PAMP | 8 |
| P<0.001 | 8 |
| Organdysfunktion | 8 |
| OctaplasLG | 8 |
| OP | 8 |
| North | 8 |
| Neonatal | 8 |
| ISTH | 8 |
| ABG | 8 |
| IRA | 8 |
| CIS | 8 |
| CD25 | 8 |
| CD11 | 8 |
| CCRT | 8 |
| CBA | 8 |
| CASP | 8 |
| Bypass | 8 |
| Bundle | 8 |
| Beeinträchtigung | 8 |
| BLS | 8 |
| BALF | 8 |
| Apta-1 | 8 |
| Annane | 8 |
| AVP | 8 |
| AFACS | 8 |
| AB | 8 |
| -9 | 8 |
| -80 | 8 |
| -8 | 8 |
| -4 | 8 |
| (= | 8 |
| Q | 8 |
| CDlla | 8 |
| CL | 8 |
| IL-16 | 8 |
| CPG10101 | 8 |
| IIb | 8 |
| IGF | 8 |
| IFϒ | 8 |
| IFNα | 8 |
| I0 | 8 |
| Hotchkiss | 8 |
| Herzens | 8 |
| Harvard | 8 |
| HRQoL | 8 |
| GVHD | 8 |
| Frailty | 8 |
| FO | 8 |
| FMD | 8 |
| Ele | 8 |
| ES | 8 |
| EHEC | 8 |
| E5 | 8 |
| Deutschland | 8 |
| Cytomegalovirus | 8 |
| Chlamydia | 8 |
| Chang | 8 |
| Pv | 8 |
| IGF-1 | 8 |
| RP | 8 |
| lh | 8 |
| np | 8 |
| ne | 8 |
| mitogen | 8 |
| meropenem | 8 |
| meist | 8 |
| mehreren | 8 |
| mean | 8 |
| mAbs | 8 |
| lung | 8 |
| linear | 8 |
| leucocytes | 8 |
| deren | 8 |
| kappaB | 8 |
| indiziert | 8 |
| immer | 8 |
| identifi | 8 |
| erniedrigten | 8 |
| empfohlen | 8 |
| ebenfalls | 8 |
| e. | 8 |
| ° | 8 |
| disease | 8 |
| p.g | 8 |
| p=0.001 | 8 |
| p=0.003 | 8 |
| p=0.03 | 8 |
| RRI | 8 |
| ~he | 8 |
| zunächst | 8 |
| zeigt | 8 |
| weitere | 8 |
| venösen | 8 |
| transthoracic | 8 |
| tachypnea | 8 |
| stehen | 8 |
| sivelestat | 8 |
| sepsis | 8 |
| sec | 8 |
| sc | 8 |
| sTREM-1 | 8 |
| s.c | 8 |
| reduziert | 8 |
| rasch | 8 |
| ra | 8 |
| polyneuromyopathy | 8 |
| plasmin | 8 |
| pO2 | 8 |
| df | 8 |
| response | 8 |
| cv | 8 |
| Task | 8 |
| THR | 8 |
| TGF-131 | 8 |
| Switzerland | 8 |
| Stickoxidsynthase | 8 |
| Software | 8 |
| Simplified | 8 |
| Sigma | 8 |
| Schmidt | 8 |
| Schlagarbeitsindex | 8 |
| Sands | 8 |
| San | 8 |
| SPICE | 8 |
| SLS | 8 |
| SES | 8 |
| SDUF | 8 |
| SDD | 8 |
| S3T2 | 8 |
| Ruß | 8 |
| Resolvin | 8 |
| RU | 8 |
| ceils | 8 |
| TISS | 8 |
| SF | 8 |
| Technology | 8 |
| Volumentherapie | 8 |
| caspase-1 | 8 |
| Thrombolyse | 8 |
| besonders | 8 |
| beschrieben | 8 |
| association | 8 |
| anergy | 8 |
| Zeichen | 8 |
| Zealand | 8 |
| Warning | 8 |
| Vs | 8 |
| aCO | 8 |
| Verlust | 8 |
| VCM | 8 |
| UFR | 8 |
| Ventilator | 8 |
| Tokyo | 8 |
| UFRV | 8 |
| Untersuchungen | 8 |
| VAN | 8 |
| VTI | 8 |
| Ventilation | 8 |
| IL-5 | 7 |
| Hämofi | 7 |
| Hämodynamisch | 7 |
| Häufi | 7 |
| Hypoxie | 7 |
| I1 | 7 |
| ICUAW | 7 |
| IPAF | 7 |
| IL10 | 7 |
| IP3 | 7 |
| Immunoglobulins | 7 |
| Implantation | 7 |
| Hrsg | 7 |
| Insuffi | 7 |
| Infusion | 7 |
| Hydrocortisone | 7 |
| Gefäße | 7 |
| Hosmer | 7 |
| GeneChip | 7 |
| Force | 7 |
| Interleukin-1 | 7 |
| Funktion | 7 |
| Fv | 7 |
| G1 | 7 |
| GFR | 7 |
| GeneChips | 7 |
| Herzstillstand | 7 |
| H202 | 7 |
| HABP | 7 |
| HAI | 7 |
| HBP | 7 |
| Hamilton | 7 |
| Heparin | 7 |
| Interferon | 7 |
| MD-2 | 7 |
| Janeiro | 7 |
| Martin | 7 |
| Linie | 7 |
| Lipid | 7 |
| Lungen | 7 |
| MC | 7 |
| MNC | 7 |
| Maresin | 7 |
| Mechanical | 7 |
| Japanese | 7 |
| Minderperfusion | 7 |
| Multiorganversagen | 7 |
| M~ | 7 |
| NADPH | 7 |
| NEWS | 7 |
| Ferrari | 7 |
| Limulus | 7 |
| Lidocain | 7 |
| LiCl | 7 |
| Lewis | 7 |
| Lemeshow | 7 |
| Lee | 7 |
| La | 7 |
| LEW | 7 |
| LAK | 7 |
| Korea | 7 |
| Konzentrationen | 7 |
| Klinikum | 7 |
| Klinik | 7 |
| Klasse | 7 |
| King | 7 |
| Kardiomyopathie | 7 |
| KE | 7 |
| Fluid | 7 |
| Albert | 7 |
| FRC | 7 |
| Asia | 7 |
| Akt | 7 |
| Aktivität | 7 |
| NM | 7 |
| Albumin | 7 |
| Animal | 7 |
| Arginin | 7 |
| Atemwege | 7 |
| Blutungen | 7 |
| BALB | 7 |
| BD | 7 |
| BF | 7 |
| Bakterien | 7 |
| Befunde | 7 |
| Bernard | 7 |
| Adrenozeptoragonisten | 7 |
| Academy | 7 |
| Abschätzung | 7 |
| Abhängigkeit | 7 |
| AQP4 | 7 |
| ANP | 7 |
| ANA773 | 7 |
| ALT | 7 |
| AL | 7 |
| AFC | 7 |
| AED | 7 |
| ABP | 7 |
| A23187 | 7 |
| 8) | 7 |
| 7PO | 7 |
| 123I | 7 |
| -+ | 7 |
| BiPAP | 7 |
| Brain | 7 |
| FPR2 | 7 |
| Dysfunction | 7 |
| Day | 7 |
| Defensins | 7 |
| Dementia | 7 |
| Dosis | 7 |
| Drug | 7 |
| Durchblutung | 7 |
| ECC | 7 |
| Brazil | 7 |
| EDs | 7 |
| ETT | 7 |
| Early | 7 |
| Enterococcus | 7 |
| Enzephalopathie | 7 |
| FDA | 7 |
| DKA | 7 |
| DDIVC | 7 |
| DCD | 7 |
| Cse | 7 |
| CsA | 7 |
| Crohn | 7 |
| Complement | 7 |
| Clinic | 7 |
| Chen | 7 |
| CRBSI | 7 |
| CP | 7 |
| CDllb | 7 |
| CC3 | 7 |
| CBC | 7 |
| CASS | 7 |
| C3H | 7 |
| C20 | 7 |
| NIPPV | 7 |
| Infection | 7 |
| NO2 | 7 |
| endosomal | 7 |
| davon | 7 |
| denen | 7 |
| dyn | 7 |
| edn | 7 |
| einzelnen | 7 |
| en | 7 |
| endothelin-1 | 7 |
| bio | 7 |
| entweder | 7 |
| entwickelt | 7 |
| eritoran | 7 |
| fed | 7 |
| formyl | 7 |
| gegen | 7 |
| ct | 7 |
| bewirkt | 7 |
| gm | 7 |
| Während | 7 |
| WF | 7 |
| WHO | 7 |
| Weise | 7 |
| Wesentlichen | 7 |
| Working | 7 |
| World | 7 |
| adäquater | 7 |
| belegt | 7 |
| aeruginosa | 7 |
| agalactiae | 7 |
| akute | 7 |
| antiXa | 7 |
| antiinfl | 7 |
| behandelt | 7 |
| gene | 7 |
| hepatitis | 7 |
| WBCT | 7 |
| thromboplastin | 7 |
| resolvin | 7 |
| rst | 7 |
| s.s | 7 |
| sevoflurane | 7 |
| siRNA | 7 |
| systemische | 7 |
| ungünstige | 7 |
| postinjury | 7 |
| verschiedenen | 7 |
| ward | 7 |
| während | 7 |
| zumindest | 7 |
| µg | 7 |
| NPR | 7 |
| proBNP | 7 |
| plasma | 7 |
| höheren | 7 |
| lipoxin | 7 |
| immunoparalysis | 7 |
| initialen | 7 |
| inotrope | 7 |
| kPa | 7 |
| l0 | 7 |
| le | 7 |
| länger | 7 |
| p=0.012 | 7 |
| microthrombi | 7 |
| möglicherweise | 7 |
| müssen | 7 |
| n=17 | 7 |
| nadroparin | 7 |
| p<0,05 | 7 |
| WEHI | 7 |
| lassen | 7 |
| W. | 7 |
| RRCV | 7 |
| Prophylaxe | 7 |
| Pulmonary | 7 |
| Pulsion | 7 |
| Pumpfunktion | 7 |
| RI | 7 |
| RIA | 7 |
| Ramsay | 7 |
| ProCT | 7 |
| Ranson | 7 |
| Reactive | 7 |
| Res | 7 |
| Respiratory | 7 |
| Rev | 7 |
| Rickettsia | 7 |
| Prondzinsky | 7 |
| Preterm | 7 |
| Ruptur | 7 |
| PCU | 7 |
| Neutropenic | 7 |
| Verfügung | 7 |
| Nicht | 7 |
| OLC | 7 |
| PBO | 7 |
| PCO | 7 |
| PCWP | 7 |
| PUFA | 7 |
| PD-1 | 7 |
| PECAM | 7 |
| PF | 7 |
| POCT | 7 |
| PRE | 7 |
| PTCA | 7 |
| Risk | 7 |
| Point | 7 |
| SF-36 | 7 |
| TSH | 7 |
| THP-1 | 7 |
| TISS-28 | 7 |
| TK | 7 |
| TLR4-MD-2 | 7 |
| TLR7/8 | 7 |
| TNFct | 7 |
| Taiwan | 7 |
| TGFβ | 7 |
| Taurolidine | 7 |
| VABP | 7 |
| VAT | 7 |
| SHR | 7 |
| VRE | 7 |
| Vasokonstriktion | 7 |
| TH | 7 |
| TNFbp | 7 |
| TBARS | 7 |
| Square | 7 |
| Scoring | 7 |
| Se | 7 |
| Sauerstoffradikale | 7 |
| Sinne | 7 |
| Sp | 7 |
| South | 7 |
| Statistical | 7 |
| Support | 7 |
| SveDem | 7 |
| Systeme | 7 |
| Systemic | 7 |
| T6 | 7 |
| Hypothermie | 6 |
| Jean | 6 |
| Hz | 6 |
| Hämodynamik | 6 |
| ICNARC | 6 |
| IIT | 6 |
| IL-9 | 6 |
| IMO-2125 | 6 |
| Immun | 6 |
| Internal | 6 |
| Immunexpress | 6 |
| Infarkt | 6 |
| Infections | 6 |
| Infirmary | 6 |
| Influenza | 6 |
| Israel | 6 |
| Intravasalraum | 6 |
| Ira | 6 |
| Jan | 6 |
| Hochrisiko | 6 |
| Hydrocortison | 6 |
| GLN | 6 |
| Herzfrequenzvariabilität | 6 |
| Gewebe | 6 |
| FT | 6 |
| Ficoll | 6 |
| Kardiomyozyten | 6 |
| Fifth | 6 |
| Fällen | 6 |
| GEDI | 6 |
| GEDVI | 6 |
| GOS | 6 |
| Groups | 6 |
| Herpes | 6 |
| Gung | 6 |
| HIPEC | 6 |
| HM | 6 |
| HPA | 6 |
| HRQOL | 6 |
| HRV | 6 |
| HeJ | 6 |
| Hemoperfusion | 6 |
| Kammerfl | 6 |
| Mycobacterium | 6 |
| Knaus | 6 |
| Kompression | 6 |
| Mean | 6 |
| Mechanisms | 6 |
| Metformin | 6 |
| Microbiology | 6 |
| Mikrozirkulation | 6 |
| MoAb | 6 |
| Moore | 6 |
| Murray | 6 |
| Möglichkeiten | 6 |
| NALP | 6 |
| NAS | 6 |
| NDM | 6 |
| NKT | 6 |
| NO˙ | 6 |
| NP | 6 |
| NPY | 6 |
| Nav | 6 |
| FB | 6 |
| Nebenwirkungen | 6 |
| Mast | 6 |
| Maschine | 6 |
| Marshall | 6 |
| Leukozyten | 6 |
| Kreislaufstabilisierung | 6 |
| L-6 | 6 |
| LAP | 6 |
| LD50 | 6 |
| LPO | 6 |
| LSF | 6 |
| LTC4 | 6 |
| Letalitätssenkung | 6 |
| Liu | 6 |
| MPs | 6 |
| Lungenödems | 6 |
| M.D. | 6 |
| M6 | 6 |
| MCF | 6 |
| MCI | 6 |
| ME | 6 |
| MHCII | 6 |
| MICU | 6 |
| FRG | 6 |
| AZ | 6 |
| F6H8 | 6 |
| Experimental | 6 |
| Anaesthetists | 6 |
| Azidose | 6 |
| B19 | 6 |
| BB | 6 |
| BCPR | 6 |
| BGA | 6 |
| BL | 6 |
| BTLA | 6 |
| BV | 6 |
| Bcl-2 | 6 |
| Beim | 6 |
| Bikarbonat | 6 |
| Biomarkers | 6 |
| Box | 6 |
| Burns | 6 |
| C3b | 6 |
| C5 | 6 |
| CCO | 6 |
| CCU | 6 |
| Alzheimer | 6 |
| Ala | 6 |
| Agitation | 6 |
| AEAT | 6 |
| Neutrophils | 6 |
| 2C | 6 |
| 6.4.7 | 6 |
| AAT | 6 |
| AAV | 6 |
| ABC | 6 |
| AC | 6 |
| ACC | 6 |
| AF | 6 |
| Activity | 6 |
| AHRF | 6 |
| ALX | 6 |
| AMG | 6 |
| ANI | 6 |
| APACHEII | 6 |
| APTT | 6 |
| AS | 6 |
| AUD | 6 |
| CD-1 | 6 |
| CD19 | 6 |
| CD52 | 6 |
| ENC | 6 |
| DPI | 6 |
| DPP | 6 |
| DS | 6 |
| DSM | 6 |
| Database | 6 |
| Diagnostics | 6 |
| Division | 6 |
| Dublin | 6 |
| EPI | 6 |
| DD | 6 |
| Edwards | 6 |
| Effekt | 6 |
| Effi | 6 |
| Einschränkung | 6 |
| El | 6 |
| Erkrankungen | 6 |
| Erwachsenen | 6 |
| Euroscore | 6 |
| DNS | 6 |
| DCs | 6 |
| CEM | 6 |
| CYP3A5 | 6 |
| CLSI | 6 |
| CO2 | 6 |
| CPP | 6 |
| CPZ | 6 |
| CSA | 6 |
| CTH | 6 |
| CVVHDF | 6 |
| CXCL8 | 6 |
| Caco-2 | 6 |
| Cx32 | 6 |
| Canada | 6 |
| Citrate | 6 |
| Cleveland | 6 |
| Cohen | 6 |
| Comorbidity | 6 |
| Con | 6 |
| Correlation | 6 |
| Council | 6 |
| Nepal | 6 |
| Thl | 6 |
| Nierenversagen | 6 |
| liegt | 6 |
| gesteigert | 6 |
| grey | 6 |
| günstige | 6 |
| hematoxylin | 6 |
| hemolysin | 6 |
| hoch | 6 |
| hohe | 6 |
| hohen | 6 |
| hypodynamic | 6 |
| hypoxemic | 6 |
| hämorrhagischen | 6 |
| ibu | 6 |
| immern | 6 |
| inotropen | 6 |
| intrapartum | 6 |
| jährlich | 6 |
| kausale | 6 |
| kcal | 6 |
| kgBW | 6 |
| gemacht | 6 |
| geht | 6 |
| gefolgt | 6 |
| cytomegalovirus | 6 |
| bisher | 6 |
| caspofungin | 6 |
| cefazolin | 6 |
| citrate | 6 |
| corticotropin | 6 |
| craniectomy | 6 |
| crystalloid | 6 |
| crystalloids | 6 |
| dL | 6 |
| ganz | 6 |
| death-1 | 6 |
| dienen | 6 |
| dient | 6 |
| direkten | 6 |
| dobutamine | 6 |
| erfolgen | 6 |
| erhöhten | 6 |
| erst | 6 |
| lb | 6 |
| limulus | 6 |
| bekannt | 6 |
| linksventrikulären | 6 |
| selbst | 6 |
| septischer | 6 |
| sofortige | 6 |
| t2 | 6 |
| tadalafil | 6 |
| transpulmonary | 6 |
| vermindert | 6 |
| wesentlich | 6 |
| wirken | 6 |
| wurde | 6 |
| wurden | 6 |
| zahlreichen | 6 |
| ~l | 6 |
| ~s | 6 |
| ~x | 6 |
| « | 6 |
| ΔPpl | 6 |
| Nikon | 6 |
| ϭ | 6 |
| relativ | 6 |
| raschen | 6 |
| rasche | 6 |
| nicaraven | 6 |
| mCD14 | 6 |
| mi | 6 |
| microRNAs | 6 |
| mittleren | 6 |
| monocytogenes | 6 |
| myeloperoxidase | 6 |
| n=20 | 6 |
| n=30 | 6 |
| nitions | 6 |
| purpura | 6 |
| p=0.025 | 6 |
| p=0.035 | 6 |
| pa | 6 |
| phagocyte | 6 |
| polymorphonuclear | 6 |
| protectin | 6 |
| protein | 6 |
| protein-1 | 6 |
| biopterin | 6 |
| pc | 6 |
| ausreichend | 6 |
| Severity | 6 |
| ROTEM | 6 |
| RRSD | 6 |
| Ranitidine | 6 |
| Red | 6 |
| Release | 6 |
| Rho | 6 |
| Rhythmusstörungen | 6 |
| Rivers | 6 |
| S2 | 6 |
| SD-101 | 6 |
| SEPSIS | 6 |
| SHD | 6 |
| SMR | 6 |
| SPV | 6 |
| STEMI | 6 |
| Seattle | 6 |
| Second | 6 |
| Service | 6 |
| Seurat | 6 |
| RCTs | 6 |
| RB | 6 |
| RANTES | 6 |
| PIRE | 6 |
| Nitroprussidnatrium | 6 |
| OC | 6 |
| allen | 6 |
| OETTH | 6 |
| Objectives | 6 |
| Outcomes | 6 |
| PECAM-1 | 6 |
| PG | 6 |
| PTT | 6 |
| RAAS | 6 |
| PVD | 6 |
| PaCO2 | 6 |
| Pathophysiologie | 6 |
| Physicians | 6 |
| Plan | 6 |
| Pulmonalarterienkatheter | 6 |
| Pumpversagen | 6 |
| Quality | 6 |
| Severinghaus | 6 |
| Practice | 6 |
| Signal | 6 |
| Tissue | 6 |
| Toronto | 6 |
| Trotz | 6 |
| U. | 6 |
| UA | 6 |
| Upregulation | 6 |
| VIII | 6 |
| VIP | 6 |
| VTE | 6 |
| Veterans | 6 |
| Volumen | 6 |
| Vordergrund | 6 |
| Vorhoffl | 6 |
| Wert | 6 |
| X | 6 |
| XII | 6 |
| aktive | 6 |
| Smad3 | 6 |
| Youden | 6 |
| adäquate | 6 |
| Tn | 6 |
| Vincent | 6 |
| Thrombozyten | 6 |
| TNFRSF1B | 6 |
| State | 6 |
| St | 6 |
| Stimuli | 6 |
| Spezifi | 6 |
| Syn-1 | 6 |
| T2.5 | 6 |
| TEE | 6 |
| THY | 6 |
| TN3 | 6 |
| T2MR | 6 |
| TP | 6 |
| TVD | 6 |
| Thiemermann | 6 |
| Tanak | 6 |
| Tachykardie | 6 |
| TNFab | 6 |
| Tagen | 6 |
| GmbH | 5 |
| HA330 | 5 |
| HICP | 5 |
| HASS | 5 |
| HADS | 5 |
| Grosshadern | 5 |
| Groupe | 5 |
| GraphPad | 5 |
| Granulozyten | 5 |
| Gerlach | 5 |
| HSP-72 | 5 |
| Gesellschaft | 5 |
| HIG | 5 |
| Hämatokrit | 5 |
| Healthcare | 5 |
| Herzzeitvolumens | 5 |
| Hoffmann | 5 |
| Hps | 5 |
| Hydroxyäthylstärke | 5 |
| Hypertonie | 5 |
| IL-1B | 5 |
| IBU | 5 |
| ICD-10 | 5 |
| IE | 5 |
| IG | 5 |
| Gefäßwiderstandes | 5 |
| IL-23 | 5 |
| IGS | 5 |
| Genomics | 5 |
| Erythrozytenkonzentraten | 5 |
| GT | 5 |
| Ex | 5 |
| Elizabeth | 5 |
| Eli | 5 |
| IPF | 5 |
| EnLiSense | 5 |
| Endotoxemia | 5 |
| England | 5 |
| Enterobacterales | 5 |
| Entzündungsreaktion | 5 |
| Ereignis | 5 |
| Erfolg | 5 |
| Erhöhung | 5 |
| Erkrankung | 5 |
| Ethical | 5 |
| Expertenforum | 5 |
| GRO | 5 |
| FDP | 5 |
| FI | 5 |
| FIBRYGA | 5 |
| FM | 5 |
| Faktor | 5 |
| Fang | 5 |
| Fever | 5 |
| Fondazione | 5 |
| Fresenius | 5 |
| Frühphase | 5 |
| Fälle | 5 |
| Füllungsdrücke | 5 |
| GABA | 5 |
| INH | 5 |
| MPM | 5 |
| IRCCS | 5 |
| Mengen | 5 |
| MCP | 5 |
| MELD | 5 |
| MEWS | 5 |
| MF | 5 |
| MG | 5 |
| MMP-8 | 5 |
| MMSE | 5 |
| MOI | 5 |
| MSOF | 5 |
| MTP | 5 |
| Madrid | 5 |
| Medikamente | 5 |
| Memorial | 5 |
| Mental | 5 |
| ITBVI | 5 |
| Mer | 5 |
| Military | 5 |
| Ministry | 5 |
| Mit | 5 |
| Mittel | 5 |
| Mo | 5 |
| Mucosal | 5 |
| Multiorgan | 5 |
| Multiorganversagens | 5 |
| Multiple | 5 |
| Muskelrelaxanzien | 5 |
| Eadi | 5 |
| Myc | 5 |
| MAC | 5 |
| LSC | 5 |
| LS | 5 |
| LPS2 | 5 |
| Identification | 5 |
| Idylla | 5 |
| IgMA | 5 |
| Illness | 5 |
| Immunonutrition | 5 |
| Immunsystems | 5 |
| Indikation | 5 |
| Induction | 5 |
| Infarktpatienten | 5 |
| Institutional | 5 |
| Interstitium | 5 |
| Intoxikationen | 5 |
| Intubation | 5 |
| Investigators | 5 |
| Jackson | 5 |
| Jeck | 5 |
| KPI | 5 |
| Kaskade | 5 |
| Kombination | 5 |
| Konzept | 5 |
| Krankenhaus | 5 |
| Kreislaufs | 5 |
| Kriterien | 5 |
| LAD | 5 |
| LB | 5 |
| LECAM | 5 |
| LEV | 5 |
| Einfl | 5 |
| Ang-2 | 5 |
| ESBL | 5 |
| Austria | 5 |
| Affairs | 5 |
| Aim | 5 |
| Allgemeinreaktion | 5 |
| Am | 5 |
| Amsterdam | 5 |
| Andexanet | 5 |
| Annual | 5 |
| Anteil | 5 |
| Anticoagulation | 5 |
| Antwort | 5 |
| Area | 5 |
| Aufgrund | 5 |
| Ausnahme | 5 |
| BCAA | 5 |
| EP | 5 |
| BDL | 5 |
| BFPCR | 5 |
| BIPAP | 5 |
| BOS | 5 |
| Bartonella | 5 |
| Baue | 5 |
| Baxter | 5 |
| Bb | 5 |
| Beginn | 5 |
| Begriff | 5 |
| Behring | 5 |
| Berger | 5 |
| Besserung | 5 |
| Aerogen | 5 |
| Activities | 5 |
| Achse | 5 |
| Abciximab | 5 |
| NADH | 5 |
| -2 | 5 |
| -Barcelona | 5 |
| /K | 5 |
| 5mg | 5 |
| 6.2.6 | 5 |
| 8h | 5 |
| A3KO | 5 |
| ACD | 5 |
| ACGA | 5 |
| ADH | 5 |
| ADVOS | 5 |
| AEC | 5 |
| AHF | 5 |
| AKIN | 5 |
| ANA975 | 5 |
| ANS | 5 |
| ANV | 5 |
| AOC | 5 |
| APTTR | 5 |
| ARG | 5 |
| AROS | 5 |
| ASV | 5 |
| ATF3 | 5 |
| ATS/ | 5 |
| AVA | 5 |
| AVM | 5 |
| Biocartis | 5 |
| Biotest | 5 |
| Blue | 5 |
| Catheter | 5 |
| Children | 5 |
| Class | 5 |
| Co | 5 |
| CoNS | 5 |
| Commons | 5 |
| Cooperative | 5 |
| Corning | 5 |
| Coronary | 5 |
| Cp | 5 |
| Creatinine | 5 |
| Creative | 5 |
| Criteria | 5 |
| Cryelan | 5 |
| DEFA3 | 5 |
| Dallas | 5 |
| Ddimer | 5 |
| Delta | 5 |
| Demzufolge | 5 |
| Dennoch | 5 |
| Departments | 5 |
| Diagnosestellung | 5 |
| Diskussion | 5 |
| E5564 | 5 |
| ECCO2R | 5 |
| EG | 5 |
| EIS | 5 |
| EMT | 5 |
| Chemokines | 5 |
| Cardiology | 5 |
| Blut | 5 |
| CVS | 5 |
| Blutverlust | 5 |
| Buchman | 5 |
| Building | 5 |
| Burn | 5 |
| C80 | 5 |
| C9 | 5 |
| CASPRI | 5 |
| CB | 5 |
| CCE | 5 |
| CCH | 5 |
| CD35 | 5 |
| CD36 | 5 |
| CD69 | 5 |
| CDI8 | 5 |
| CES | 5 |
| CF | 5 |
| CGT | 5 |
| CIM | 5 |
| CKD | 5 |
| CMG | 5 |
| COX-2 | 5 |
| CPK | 5 |
| CQC | 5 |
| CR | 5 |
| CRS | 5 |
| CTLA-4 | 5 |
| CTPA | 5 |
| Myocardial | 5 |
| international | 5 |
| NEP | 5 |
| hilfreich | 5 |
| ester | 5 |
| etomidate | 5 |
| filgrastim | 5 |
| fos | 5 |
| freq | 5 |
| g. | 5 |
| geprägt | 5 |
| gerechnet | 5 |
| großer | 5 |
| gt | 5 |
| haemodynamic | 5 |
| herpes | 5 |